You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Greener and More Energy Efficient Renewable Energy Resource-Geothermal Heat Pumps

    SBC: ACTA Technology            Topic: N/A

    "Given the exigency to rein in our nation’s energy consumption and carbon emissions, a nationwide deployment of Geothermal Heat Pumps (GHPs) would help mitigate our demands on the earth’s resources by reducing energy requirements for heating and cooling. Geothermal Heat Pump systems are a proven renewable energy resource that provides significant energy savings as compared to typical heating ...

    SBIR Phase I 2011 Environmental Protection Agency
  2. Low Temperature Stirling Engine for Waste Heat Recovery from Distributed Power Sources

    SBC: Cool Energy, Inc.            Topic: A

    "Since March 2006, Boulder, Colorado based Cool Energy, Inc. (CEI) has prototyped three generations of a novel low-temperature Stirling engine to generate electricity for low-to-medium temperature (100°C to 250°C) heat sources including solar thermal, geothermal and waste heat. With a marketing name for the SolarHeart® Engine, in its most recent operation in April, 2010, over 1800 watts of out ...

    SBIR Phase I 2011 Environmental Protection Agency
  3. A Solvent-Free, Nanopowder Production Method

    SBC: ELTRON RESEARCH & DEVELOPMENT, INCORPORATED            Topic: B

    "The large-scale production of nanoparticles of the highest purity will be accomplished by the Eltron Solvent-free Powder Synthesis (ESPS) system described in this proposal. Since conventional particle size reduction methods are unable to reduce particles to the nano-scale and tend to reduce the purity of the powders, the ESPS system has been designed for direct yield of high purity and nano-size ...

    SBIR Phase I 2011 Environmental Protection Agency
  4. New Sorbents to Contol CO2 and Multi-Contaminant Emissions

    SBC: TDA RESEARCH, INC.            Topic: D

    "The oil refining industry is one of the most significant sources of greenhouse gas emissions, with considerable contribution from downstream activities. CO2 emissions from refineries rank third among the stationary producers (after power and cement industries), accounting for about 4% of the global CO2 emissions, approaching 1 billion tons per year. In addition, the oil refineries also emit sig ...

    SBIR Phase I 2011 Environmental Protection Agency
  5. Advanced Contaminant Inactivation System for Drinking Water

    SBC: REACTIVE INNOVATIONS, LLC            Topic: E

    "The environmental Protection Agency is soliciting innovations for the development of small unit drinking water systems that will inactivate contaminants including pesticides, organic pollutants, pharmaceuticals, personal care products, and pathogens. In the US, 85% of all public water systems serve fewer than 3,300 people, thus these water systems are considered small. For providing these small ...

    SBIR Phase I 2011 Environmental Protection Agency
  6. A Rapid Point-of-care Diagnostic for Neisseria gonorrhoeae STDs

    SBC: NetBio, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Improved diagnosis of Neisseria gonorrhoeae (GC) infections represents a critical unmet medical need. The CDC estimates that approximately 700,000 people are infected by GC annually, with approximately half of these cases reported. The clinical spectrum of GC infection includes urethritis and cervicitis, pelvic inflammatory disease (PID), and disseminated disea ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Development of Tissue Scaffold of High Strength and Porosity

    SBC: BIO2 TECHNOLOGIES, INC.            Topic: NIAMS

    DESCRIPTION (provided by applicant): According to the Center of Disease Control and Prevention, arthritis is the greatest single cause of chronic pain and disability among Americans .2,3 Currently there is no cure for osteoarthritis, only medication and surgical procedures are available to alleviate the pain and discomfort associated with this degenerative bone disease. Current surgical treatment ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Amelioration of Claustrophobia and Disruptive Patient Motion in MR Imaging

    SBC: HYPNALGESICS, LLC            Topic: NCCAM

    DESCRIPTION (provided by applicant): Claustrophobia and disruptive patient motion are common impediments to MRI examination, but they may be prevented or ameliorated with a non-pharmacologic behavioral intervention administered by trained staff. The potential benefits of such an intervention are highly significant, considering that the alternatives are to cancel the study or administer sedation. I ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. Virus-Targeted Therapy for Malignancies

    SBC: Phoenicia Biosciences, Inc.            Topic: NCI

    DESCRIPTION (provided by applicant): Epstein-Barr virus (EBV) is associated with a number of human malignancies for which there are presently few effective treatments. Lymphoid malignancies caused by, or associated with, Epstein-Barr virus include Burkitt's lymphoma, T/NK lymphomas, some T- and B-cell lymphomas, approximately half of Hodgkin's lymphomas and all post-transplant lymphopro ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. Rapid Testing of Drug-Resistant BCR-ABL(+)Leukemia Cells

    SBC: BIOSENSE TECHNOLOGIES, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Resistance to chemotherapeutic drugs is an ongoing problem that results in eventual treatment failures or suboptimal patient outcomes. In cancer cells treated with drugs to which they are sensitive, the stress responseis the first step in the subsequent cascade leading to cell death (apoptotic, necrotic or autophagy). The recent availability of a sensing modali ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government